Results 221 to 230 of about 156,767 (359)

A meta-analysis on racial disparity in administration of tissue plasminogen activator (tPA) in stroke patients. [PDF]

Health Sci Rep
Larik MO, Bhattarai P.
europepmc   +1 more source

The Role of Matrix Metalloproteinases in Hemorrhagic Transformation in the Treatment of Stroke with Tissue Plasminogen Activator. [PDF]

J Pers Med, 2023
Babenko VA, Fedulova KS, Silachev DN, Rahimi-Moghaddam P, Kalyuzhnaya YN, Demyanenko SV, Plotnikov EY.   +6 more
europepmc   +1 more source

Production of monoclonal antibodies to the high fibrin-affinity, tissue- type plasminogen activator of human plasma. Demonstration of its endothelial origin by immunolocalization [PDF]

, 1985
Eduardo Anglés‐Cano, A Balaton, B Le Bonniec, E Genot, J Elion, Y Sultan   +5 more
openalex   +1 more source

Correlation between subretinal tissue plasminogen activator and air injection rates with pressure in a retina mimicking model. [PDF]

Sci Rep
Kim NH, Lee M, Chung H, Kim HC, Lee H.
europepmc   +1 more source

Efficacy of Urinary Kallidinogenase Plus Intravenous Recombinant Tissue Plasminogen Activator for Stroke Patients With Extended Window: A Retrospective Analysis. [PDF]

Neurologist, 2023
Li X, Zhang X, Yang Y, Wang H, Zhang J.
europepmc   +1 more source

Purification of human tissue plasminogen activator with Erythrina trypsin inhibitor.

, 1984
Christa Heussen, F Joubert, Eugene B. Dowdle   +2 more
openalex   +1 more source

Health and economic benefits of improving pre‐hospital identification of stroke in Australian women: a modelling study

Medical Journal of Australia, EarlyView.
Abstract Objective To estimate the long term gains in life years and quality‐adjusted life years (QALYs) and the cost savings that could be achieved if ischaemic stroke was identified in women with the same level of accuracy received by men, versus the status quo. Design Decision tree and Markov model decision analysis.
Thomas Gadsden, Lei Si, Emily R Atkins, Cheryl Carcel, Xia Wang, Stephen Jan, Mark Woodward, Laura E Downey   +7 more
wiley   +1 more source

Identification of the Domains of Tissue-type Plasminogen Activator Involved in the Augmented Binding to Fibrin after Limited Digestion with Plasmin

, 1989
C. de Vries, Harry Veerman, Hans Pannekoek   +2 more
openalex   +1 more source

Development and Validation of a Liquid Chromatography High‐Resolution Mass Spectrometry Method for Blood Desmopressin Quantification and Its Application in Hemophilia A Patients

Rapid Communications in Mass Spectrometry, Volume 39, Issue 18, 30 September 2025.
ABSTRACT Desmopressin (DDAVP), which indirectly increases Coagulation Factor VIII concentrations in the blood, is a common treatment for bleeding disorders such as von Willebrand disease or hemophilia A. However, DDAVP exhibits significant variability in response due to interindividual differences in pharmacokinetics.
Sophie Hodin, Jean Escal, Catherine Feliu, Adeline Pontis, Laurie Josset, Adrian Serban, Benoît Guillet, Xavier Delavenne   +7 more
wiley   +1 more source

Early Drainage of Macula-Involving Massive Suprachoroidal Haemorrhage Assisted with Recombinant Tissue Plasminogen Activator May Lead to Better Visual Prognosis. [PDF]

Case Rep Ophthalmol
Khalil M, Schneiders M, Veckeneer M, Depla JA, Feron E, Saidkasimova S.   +5 more
europepmc   +1 more source